Literature DB >> 14769255

Long-acting beta agonists in asthma therapy.

Richard W Rissmiller1, Michael J Larj, Stephen P Peters.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14769255     DOI： 10.1007/s11882-004-0049-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


× No keyword cloud information.
  6 in total

1.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.

Authors:  E Israel; J M Drazen; S B Liggett; H A Boushey; R M Cherniack; V M Chinchilli; D M Cooper; J V Fahy; J E Fish; J G Ford; M Kraft; S Kunselman; S C Lazarus; R F Lemanske; R J Martin; D E McLean; S P Peters; E K Silverman; C A Sorkness; S J Szefler; S T Weiss; C N Yandava
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

2.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

Authors:  C M Drysdale; D W McGraw; C B Stack; J C Stephens; R S Judson; K Nandabalan; K Arnold; G Ruano; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

3.  Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma.

Authors:  Annika Wallin; Malcolm Sue-Chu; Leif Bjermer; Jonathan Ward; Thomas Sandström; Anne Lindberg; Bo Lundbäck; Ratko Djukanović; Stephen Holgate; Susan Wilson
Journal:  J Allergy Clin Immunol       Date:  2003-07       Impact factor: 10.793

4.  Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.

Authors:  Graeme P Currie; Suvi Stenback; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

5.  Serious asthma exacerbations in asthmatics treated with high-dose formoterol.

Authors:  Marianne Mann; Badrul Chowdhury; Eugene Sullivan; Richard Nicklas; Raymond Anthracite; Robert J Meyer
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

6.  Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.

Authors:  D W Reid; C Ward; N Wang; L Zheng; R Bish; B Orsida; E H Walters
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.